MERUS LABS INTERNATIONAL INC.
TO: | British Columbia Securities Commission |
Ontario Securities Commission | |
Autorité des marchés financiers | |
Alberta Securities Commission | |
Financial and Consumer Affairs Authority of Saskatchewan | |
Manitoba Securities Commission | |
New Brunswick Securities Commission | |
Prince Edward Island Securities Office | |
-and- | |
MNP LLP, Chartered Professional Accountants | |
-and- | |
Deloitte LLP, Chartered Professional Accountants, Chartered Accountants, Licensed Public | |
Accountants | |
RE: | Notice of Change of Auditor pursuant to Section 4.11 of National Instrument 51-102 – |
Continuous Disclosure Obligations |
Pursuant to Section 4.11(7) of National Instrument 51-102, Merus Labs International Inc. (the “Company”) hereby gives notice of the change of its auditor from Deloitte LLP to MNP LLP. In accordance with National Instrument 51-102, the Company hereby states that:
1. | Deloitte LLP resigned at our request as the Company’s auditor, effective June 27, 2014; |
2. | MNP LLP has been appointed as the Company’s auditor, effective July 4, 2014; |
3. | the resignation of Deloitte LLP and the appointment of MNP LLP as the Company’s auditor have been considered and approved by the Company’s Audit Committee and Board of Directors; |
4. | Deloitte LLP’s audit report on the Company’s financial statements for the year ended September 30, 2013 and September 30, 2012 did not express a modified opinion; and |
5. | there have been no “reportable events” within the meaning assigned under subsection 4.11(1) of National Instrument 51-102. |
DATED the 11th day of July, 2014.
BY ORDER OF THE BOARD OF DIRECTORS
“Andrew Patient”
Andrew Patient
Chief Financial Officer